Results 141 to 150 of about 260,714 (218)

Crossref-Metadatensuche

Archivalia, 2013
openaire   +2 more sources

Dramatic increases in redundant publications in the Generative AI era. [PDF]

BMC Med
Maupin D, Suchak T, Barnett A, Spick M.
europepmc   +1 more source

Overview of the Journal of Yeungnam Medical Science in 2025: submission trends, journal metrics, and appreciation for peer reviewers. [PDF]

J Yeungnam Med Sci
Kim TG.
europepmc   +1 more source

crossref test article

IJASS(International Journal of Applied Sports Sciences), 2020
openaire   +1 more source

A plain language summary on taking medication as prescribed for multiple sclerosis: impact on relapses, disability, and healthcare costs. [PDF]

Neurodegener Dis Manag
Amezcua L, Livingston T, Hayward B, Zhou J, Williams MJ.   +4 more
europepmc   +1 more source

Collection and Reporting of Adult Sexual Orientation and Gender Identity Data in Highly Cited Cardiovascular Research. [PDF]

Circ Popul Health Outcomes
Ponodath GS, Dewan H, Saha T, Thomas SS, Yang JC, Connolly DJ.   +5 more
europepmc   +1 more source

A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study. [PDF]

Clin Cancer Res
Alsina M, Villacampa G, de Andrea C, Vivancos A, Ponz-Sarvise M, Arrazubi V, Jimenez-Fonseca P, Diez M, Sanz-Garcia E, Martínez E, Guardeño R, Calvo M, Bugés C, Longo F, Navarro V, García-Galea E, Gros A, Ochoa MC, Lopez-Janeiro A, Sanchez-Gregorio S, Herrero C, Labiano I, Vila-Casadesús M, López D, Alexandru R, Muñoz S, Tabernero J, Melero I.   +27 more
europepmc   +1 more source

Phase Ib study of berzosertib, carboplatin, gemcitabine, and pembrolizumab in patients with squamous nonsmall lung cancer (ETCTN 10313). [PDF]

Oncologist
Villaruz LC, Schluger B, Wang H, Ohr J, Petro D, Fuld AD, Herzberg B, Dawar R, Nieva J, Ruiz J, Christner SM, Holleran JL, Bakkenist CJ, Gore S, Beumer JH.   +14 more
europepmc   +1 more source

Enpatoran, a first-in-class, selective, orally administered toll-like receptor 7/8 inhibitor, in systemic and cutaneous lupus erythematosus: results from a randomised, placebo-controlled phase Ib study. [PDF]

Lupus Sci Med
Witte T, Fernandez-Ruiz R, Abramova N, Weinelt D, Moreau F, Klopp-Schulze L, Shaw J, Denis D, Wenzel J.   +8 more
europepmc   +1 more source

Expert Opinion on Age-Related Sex Hormone Changes and Hypogonadism in People With Multiple Sclerosis: A Delphi Consensus Program. [PDF]

Neurol Clin Pract
Bove R, Simoni M, Castelo-Branco C, Correale J, Hellwig K, Houtchens MK, Magyari M, Merki-Feld G, Montgomery S, Nappi RE, Shen W, Stenager E, Thompson H, Tulek Z, Marhardt K, Hillert JA.   +15 more
europepmc   +1 more source